Thus, this study is aimed at evaluating the effect of MRS2578, as a selective P2Y6 receptor antagonist, in Angiotensin (Ang) II-induced AAA formation in apolipoprotein E-deficient (apoE−/−) mice. This evidence concerns the gene APOE and triple-A syndrome.